SWTX: SpringWorks Therapeutics, Inc. Stock

by  •  • Comments Off on SWTX: SpringWorks Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 4,456.71
Enterprise Value ($M) 4,386.95
Book Value ($M) 481.10
Book Value / Share 6.47
Price / Book 9.26
NCAV ($M) 274.29
NCAV / Share 3.69
Price / NCAV 16.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -0.36
Return on Equity (ROE) -0.41

Liquidity (mrq)
Quick Ratio 3.70
Current Ratio 3.81

Balance Sheet (mrq) ($M)
Current Assets 380.46
Assets 587.28
Liabilities 106.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 191.59
Operating Income -278.13
Net Income -258.13

Cash Flow Statement (mra) ($M)
Cash From Operations -175.60
Cash from Investing 64.55
Cash from Financing 4.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G/A Deep Track Capital, LP
01-31 13G/A Vanguard Group Inc
10-25 13G/A Boxer Capital Management, LLC 4.60
2024-02-14 13G/A EcoR1 Capital, LLC 0.00 -100.00
2024-02-09 13G/A Fmr Llc 15.00 15.48
2024-01-26 13G/A BlackRock, Inc. 7.50 61.88
2024-01-23 13G/A State Street Corp 3.64 -30.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 637,464 3,087,427 20.65
2025-02-20 561,884 3,933,801 14.28
2025-02-19 89,639 1,517,706 5.91
2025-02-18 245,918 3,140,821 7.83

(click for more detail)

Similar Companies
STOK – Stoke Therapeutics, Inc. STTK – Shattuck Labs, Inc.
SVRA – Savara Inc. SYRE – Spyre Therapeutics, Inc.
SYRS – Syros Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io